ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa05164	Influenza A	9/80	171/8144	4.147e-05	0.007174	0.006941	HLA-DRB5/RAB11B/RSAD2/SOCS3/OAS1/EIF2AK2/FASLG/IRF7/MX1	9
KEGG	hsa05160	Hepatitis C	7/80	157/8144	0.0008459	0.06444	0.06234	RSAD2/SOCS3/OAS1/EIF2AK2/FASLG/IRF7/MX1	7
KEGG	hsa04973	Carbohydrate digestion and absorption	4/80	47/8144	0.001117	0.06444	0.06234	TAS1R2/AMY1A/AMY1B/AMY1C	4
KEGG	hsa04932	Non-alcoholic fatty liver disease	6/80	155/8144	0.004069	0.1734	0.1677	SOCS3/PRKAA1/FASLG/UQCRFS1/SDHA/SREBF1	6
KEGG	hsa00500	Starch and sucrose metabolism	3/80	36/8144	0.005161	0.1734	0.1677	AMY1A/AMY1B/AMY1C	3
KEGG	hsa05330	Allograft rejection	3/80	38/8144	0.006013	0.1734	0.1677	HLA-DRB5/PRF1/FASLG	3
KEGG	hsa05332	Graft-versus-host disease	3/80	42/8144	0.007956	0.1837	0.1777	HLA-DRB5/PRF1/FASLG	3
KEGG	hsa04940	Type I diabetes mellitus	3/80	43/8144	0.008493	0.1837	0.1777	HLA-DRB5/PRF1/FASLG	3
KEGG	hsa05162	Measles	5/80	139/8144	0.01165	0.2239	0.2166	OAS1/EIF2AK2/FASLG/IRF7/MX1	5
KEGG	hsa05320	Autoimmune thyroid disease	3/80	53/8144	0.01503	0.2601	0.2516	HLA-DRB5/PRF1/FASLG	3
KEGG	hsa00563	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	2/80	26/8144	0.02659	0.4182	0.4046	PIGX/PIGY	2
KEGG	hsa00630	Glyoxylate and dicarboxylate metabolism	2/80	30/8144	0.03471	0.5004	0.4841	GLUL/CAT	2
KEGG	hsa04068	FoxO signaling pathway	4/80	131/8144	0.03961	0.5271	0.51	PRKAA1/FASLG/CAT/GABARAP	4
KEGG	hsa04210	Apoptosis	4/80	136/8144	0.04445	0.5493	0.5314	PRF1/FASLG/DIABLO/DFFA	4
KEGG	hsa04936	Alcoholic liver disease	4/80	142/8144	0.05068	0.5703	0.5518	PRKAA1/IL17RA/FASLG/SREBF1	4
KEGG	hsa05168	Herpes simplex virus 1 infection	9/80	495/8144	0.05275	0.5703	0.5518	HLA-DRB5/SOCS3/OAS1/BST2/EIF2AK2/ZNF785/FASLG/IRF7/ZNF583	9
KEGG	hsa04970	Salivary secretion	3/80	93/8144	0.06316	0.6427	0.6218	AMY1A/AMY1B/AMY1C	3
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	5/80	223/8144	0.06782	0.6518	0.6306	HGF/KEAP1/CAT/UQCRFS1/SDHA	5
KEGG	hsa04972	Pancreatic secretion	3/80	102/8144	0.07858	0.7059	0.683	AMY1A/AMY1B/AMY1C	3
KEGG	hsa04931	Insulin resistance	3/80	108/8144	0.08969	0.7059	0.683	SOCS3/PRKAA1/SREBF1	3
KEGG	hsa00920	Sulfur metabolism	1/80	10/8144	0.09405	0.7059	0.683	PAPSS1	1
KEGG	hsa00600	Sphingolipid metabolism	2/80	53/8144	0.09529	0.7059	0.683	GBA/ARSA	2
KEGG	hsa04621	NOD-like receptor signaling pathway	4/80	184/8144	0.1067	0.7059	0.683	OAS1/IRF7/GSDMD/GABARAP	4
KEGG	hsa04152	AMPK signaling pathway	3/80	120/8144	0.1137	0.7059	0.683	RAB11B/PRKAA1/SREBF1	3
KEGG	hsa04330	Notch signaling pathway	2/80	59/8144	0.114	0.7059	0.683	DTX3L/DTX1	2
KEGG	hsa05416	Viral myocarditis	2/80	60/8144	0.1172	0.7059	0.683	HLA-DRB5/PRF1	2
KEGG	hsa04213	Longevity regulating pathway - multiple species	2/80	62/8144	0.1237	0.7059	0.683	PRKAA1/CAT	2
KEGG	hsa03250	Viral life cycle - HIV-1	2/80	63/8144	0.127	0.7059	0.683	BST2/MX1	2
KEGG	hsa05169	Epstein-Barr virus infection	4/80	202/8144	0.1368	0.7059	0.683	HLA-DRB5/OAS1/EIF2AK2/IRF7	4
KEGG	hsa00603	Glycosphingolipid biosynthesis - globo and isoglobo series	1/80	15/8144	0.1377	0.7059	0.683	NAGA	1
KEGG	hsa00730	Thiamine metabolism	1/80	15/8144	0.1377	0.7059	0.683	ALPL	1
KEGG	hsa04142	Lysosome	3/80	132/8144	0.14	0.7059	0.683	GBA/NAGA/ARSA	3
KEGG	hsa04920	Adipocytokine signaling pathway	2/80	69/8144	0.1471	0.7059	0.683	SOCS3/PRKAA1	2
KEGG	hsa04910	Insulin signaling pathway	3/80	137/8144	0.1514	0.7059	0.683	SOCS3/PRKAA1/SREBF1	3
KEGG	hsa00450	Selenocompound metabolism	1/80	17/8144	0.1546	0.7059	0.683	PAPSS1	1
KEGG	hsa00910	Nitrogen metabolism	1/80	17/8144	0.1546	0.7059	0.683	GLUL	1
KEGG	hsa05418	Fluid shear stress and atherosclerosis	3/80	139/8144	0.1561	0.7059	0.683	PIAS4/KEAP1/PRKAA1	3
KEGG	hsa04140	Autophagy - animal	3/80	141/8144	0.1608	0.7059	0.683	PRKAA1/WDR41/GABARAP	3
KEGG	hsa00511	Other glycan degradation	1/80	18/8144	0.163	0.7059	0.683	GBA	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	3/80	142/8144	0.1632	0.7059	0.683	SOCS3/PIAS4/KEAP1	3
KEGG	hsa04612	Antigen processing and presentation	2/80	78/8144	0.1783	0.7194	0.696	HLA-DRB5/PSME1	2
KEGG	hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1/80	20/8144	0.1794	0.7194	0.696	CHST14	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	7/80	476/8144	0.1857	0.7194	0.696	DNAH6/FASLG/CAT/WDR41/UQCRFS1/ATXN3/SDHA	7
KEGG	hsa04145	Phagosome	3/80	152/8144	0.1876	0.7194	0.696	HLA-DRB5/RILP/COLEC11	3
KEGG	hsa04146	Peroxisome	2/80	82/8144	0.1925	0.7194	0.696	PRDX5/CAT	2
KEGG	hsa00220	Arginine biosynthesis	1/80	22/8144	0.1954	0.7194	0.696	GLUL	1
KEGG	hsa00900	Terpenoid backbone biosynthesis	1/80	22/8144	0.1954	0.7194	0.696	ICMT	1
KEGG	hsa04217	Necroptosis	3/80	159/8144	0.2051	0.7301	0.7063	EIF2AK2/GLUL/FASLG	3
KEGG	hsa04742	Taste transduction	2/80	86/8144	0.2068	0.7301	0.7063	KCNK5/TAS1R2	2
KEGG	hsa04211	Longevity regulating pathway	2/80	89/8144	0.2176	0.7382	0.7141	PRKAA1/CAT	2
KEGG	hsa04727	GABAergic synapse	2/80	89/8144	0.2176	0.7382	0.7141	GLUL/GABARAP	2
KEGG	hsa00790	Folate biosynthesis	1/80	26/8144	0.2267	0.7541	0.7296	ALPL	1
KEGG	hsa05231	Choline metabolism in cancer	2/80	98/8144	0.2503	0.7694	0.7444	DGKE/SLC22A5	2
KEGG	hsa00020	Citrate cycle (TCA cycle)	1/80	30/8144	0.2567	0.7694	0.7444	SDHA	1
KEGG	hsa01523	Antifolate resistance	1/80	30/8144	0.2567	0.7694	0.7444	ABCG2	1
KEGG	hsa04710	Circadian rhythm	1/80	31/8144	0.264	0.7694	0.7444	PRKAA1	1
KEGG	hsa05310	Asthma	1/80	31/8144	0.264	0.7694	0.7444	HLA-DRB5	1
KEGG	hsa05012	Parkinson disease	4/80	266/8144	0.2649	0.7694	0.7444	KEAP1/SLC39A14/UQCRFS1/SDHA	4
KEGG	hsa05142	Chagas disease	2/80	102/8144	0.2649	0.7694	0.7444	GNA15/FASLG	2
KEGG	hsa04136	Autophagy - other	1/80	32/8144	0.2713	0.7694	0.7444	GABARAP	1
KEGG	hsa04215	Apoptosis - multiple species	1/80	32/8144	0.2713	0.7694	0.7444	DIABLO	1
KEGG	hsa04130	SNARE interactions in vesicular transport	1/80	33/8144	0.2785	0.7771	0.7518	STX5	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	5/80	364/8144	0.2865	0.7869	0.7613	DNAH6/CAT/WDR41/UQCRFS1/SDHA	5
KEGG	hsa00512	Mucin type O-glycan biosynthesis	1/80	36/8144	0.2996	0.7915	0.7658	GALNT3	1
KEGG	hsa00250	Alanine, aspartate and glutamate metabolism	1/80	37/8144	0.3065	0.7915	0.7658	GLUL	1
KEGG	hsa01250	Biosynthesis of nucleotide sugars	1/80	37/8144	0.3065	0.7915	0.7658	UAP1	1
KEGG	hsa05143	African trypanosomiasis	1/80	37/8144	0.3065	0.7915	0.7658	FASLG	1
KEGG	hsa01200	Carbon metabolism	2/80	115/8144	0.3124	0.7947	0.7688	CAT/SDHA	2
KEGG	hsa05203	Viral carcinogenesis	3/80	204/8144	0.3244	0.8132	0.7868	HDAC9/EIF2AK2/IRF7	3
KEGG	hsa04216	Ferroptosis	1/80	41/8144	0.3335	0.8137	0.7872	SLC39A14	1
KEGG	hsa00380	Tryptophan metabolism	1/80	42/8144	0.3401	0.8137	0.7872	CAT	1
KEGG	hsa04962	Vasopressin-regulated water reabsorption	1/80	44/8144	0.3531	0.8137	0.7872	RAB11B	1
KEGG	hsa02010	ABC transporters	1/80	45/8144	0.3595	0.8137	0.7872	ABCG2	1
KEGG	hsa03050	Proteasome	1/80	46/8144	0.3658	0.8137	0.7872	PSME1	1
KEGG	hsa04930	Type II diabetes mellitus	1/80	46/8144	0.3658	0.8137	0.7872	SOCS3	1
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	2/80	131/8144	0.3698	0.8137	0.7872	PRF1/FASLG	2
KEGG	hsa00514	Other types of O-glycan biosynthesis	1/80	47/8144	0.372	0.8137	0.7872	GALNT3	1
KEGG	hsa00190	Oxidative phosphorylation	2/80	134/8144	0.3804	0.8137	0.7872	UQCRFS1/SDHA	2
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	1/80	49/8144	0.3844	0.8137	0.7872	UAP1	1
KEGG	hsa00565	Ether lipid metabolism	1/80	49/8144	0.3844	0.8137	0.7872	TMEM189	1
KEGG	hsa04672	Intestinal immune network for IgA production	1/80	49/8144	0.3844	0.8137	0.7872	HLA-DRB5	1
KEGG	hsa05144	Malaria	1/80	50/8144	0.3905	0.8137	0.7872	HGF	1
KEGG	hsa00270	Cysteine and methionine metabolism	1/80	51/8144	0.3965	0.8137	0.7872	AHCYL1	1
KEGG	hsa04714	Thermogenesis	3/80	232/8144	0.3998	0.8137	0.7872	PRKAA1/UQCRFS1/SDHA	3
KEGG	hsa05171	Coronavirus disease - COVID-19	3/80	232/8144	0.3998	0.8137	0.7872	OAS1/EIF2AK2/MX1	3
KEGG	hsa04978	Mineral absorption	1/80	60/8144	0.4481	0.8255	0.7986	MT2A	1
KEGG	hsa04144	Endocytosis	3/80	251/8144	0.4498	0.8255	0.7986	RAB11B/VPS25/ARFGAP2	3
KEGG	hsa00561	Glycerolipid metabolism	1/80	61/8144	0.4536	0.8255	0.7986	DGKE	1
KEGG	hsa04150	mTOR signaling pathway	2/80	156/8144	0.4555	0.8255	0.7986	PRKAA1/DEPDC5	2
KEGG	hsa00310	Lysine degradation	1/80	63/8144	0.4644	0.8255	0.7986	PLOD1	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/80	63/8144	0.4644	0.8255	0.7986	IRF7	1
KEGG	hsa04929	GnRH secretion	1/80	64/8144	0.4697	0.8255	0.7986	HCN3	1
KEGG	hsa05321	Inflammatory bowel disease	1/80	65/8144	0.4749	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa04630	JAK-STAT signaling pathway	2/80	162/8144	0.4751	0.8255	0.7986	SOCS3/PIAS4	2
KEGG	hsa05161	Hepatitis B	2/80	162/8144	0.4751	0.8255	0.7986	FASLG/IRF7	2
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/80	68/8144	0.4904	0.8255	0.7986	ALOX5AP	1
KEGG	hsa05225	Hepatocellular carcinoma	2/80	168/8144	0.4943	0.8255	0.7986	HGF/KEAP1	2
KEGG	hsa05211	Renal cell carcinoma	1/80	69/8144	0.4954	0.8255	0.7986	HGF	1
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/80	70/8144	0.5004	0.8255	0.7986	IRF7	1
KEGG	hsa04917	Prolactin signaling pathway	1/80	70/8144	0.5004	0.8255	0.7986	SOCS3	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	2/80	171/8144	0.5037	0.8255	0.7986	EIF2AK2/ATXN3	2
KEGG	hsa04137	Mitophagy - animal	1/80	72/8144	0.5103	0.8255	0.7986	GABARAP	1
KEGG	hsa05218	Melanoma	1/80	72/8144	0.5103	0.8255	0.7986	HGF	1
KEGG	hsa05223	Non-small cell lung cancer	1/80	72/8144	0.5103	0.8255	0.7986	HGF	1
KEGG	hsa01524	Platinum drug resistance	1/80	73/8144	0.5151	0.8255	0.7986	FASLG	1
KEGG	hsa01230	Biosynthesis of amino acids	1/80	75/8144	0.5247	0.8255	0.7986	GLUL	1
KEGG	hsa03320	PPAR signaling pathway	1/80	75/8144	0.5247	0.8255	0.7986	PLIN2	1
KEGG	hsa05010	Alzheimer disease	4/80	384/8144	0.5254	0.8255	0.7986	EIF2AK2/SLC39A14/UQCRFS1/SDHA	4
KEGG	hsa05220	Chronic myeloid leukemia	1/80	76/8144	0.5294	0.8255	0.7986	BCR	1
KEGG	hsa05140	Leishmaniasis	1/80	77/8144	0.5341	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	1/80	79/8144	0.5433	0.8255	0.7986	HGF	1
KEGG	hsa04613	Neutrophil extracellular trap formation	2/80	190/8144	0.5608	0.8255	0.7986	HDAC9/GSDMD	2
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	2/80	194/8144	0.5722	0.8255	0.7986	EIF2AK2/IRF7	2
KEGG	hsa04260	Cardiac muscle contraction	1/80	87/8144	0.5783	0.8255	0.7986	UQCRFS1	1
KEGG	hsa05016	Huntington disease	3/80	306/8144	0.5835	0.8255	0.7986	DNAH6/UQCRFS1/SDHA	3
KEGG	hsa04976	Bile secretion	1/80	89/8144	0.5866	0.8255	0.7986	ABCG2	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/80	90/8144	0.5907	0.8255	0.7986	PRKAA1	1
KEGG	hsa05206	MicroRNAs in cancer	3/80	310/8144	0.5925	0.8255	0.7986	MIR520E/MIR32/MIR181B1	3
KEGG	hsa05415	Diabetic cardiomyopathy	2/80	203/8144	0.5971	0.8255	0.7986	UQCRFS1/SDHA	2
KEGG	hsa04658	Th1 and Th2 cell differentiation	1/80	92/8144	0.5988	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa05205	Proteoglycans in cancer	2/80	205/8144	0.6025	0.8255	0.7986	HGF/FASLG	2
KEGG	hsa05323	Rheumatoid arthritis	1/80	93/8144	0.6028	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa04657	IL-17 signaling pathway	1/80	94/8144	0.6068	0.8255	0.7986	IL17RA	1
KEGG	hsa05150	Staphylococcus aureus infection	1/80	96/8144	0.6145	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/80	97/8144	0.6184	0.8255	0.7986	DGKE	1
KEGG	hsa04713	Circadian entrainment	1/80	97/8144	0.6184	0.8255	0.7986	MTNR1B	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	2/80	212/8144	0.6209	0.8255	0.7986	BST2/FASLG	2
KEGG	hsa00564	Glycerophospholipid metabolism	1/80	98/8144	0.6222	0.8255	0.7986	DGKE	1
KEGG	hsa04640	Hematopoietic cell lineage	1/80	99/8144	0.6259	0.8255	0.7986	HLA-DRB5	1
KEGG	hsa05417	Lipid and atherosclerosis	2/80	215/8144	0.6286	0.8255	0.7986	FASLG/IRF7	2
KEGG	hsa05146	Amoebiasis	1/80	102/8144	0.637	0.8255	0.7986	GNA15	1
KEGG	hsa05165	Human papillomavirus infection	3/80	331/8144	0.6373	0.8255	0.7986	EIF2AK2/FASLG/MX1	3
KEGG	hsa04974	Protein digestion and absorption	1/80	103/8144	0.6406	0.8255	0.7986	KCNK5	1
KEGG	hsa04064	NF-kappa B signaling pathway	1/80	104/8144	0.6441	0.8255	0.7986	PIAS4	1
KEGG	hsa04620	Toll-like receptor signaling pathway	1/80	104/8144	0.6441	0.8255	0.7986	IRF7	1
KEGG	hsa04922	Glucagon signaling pathway	1/80	107/8144	0.6547	0.8277	0.8008	PRKAA1	1
KEGG	hsa04659	Th17 cell differentiation	1/80	108/8144	0.6581	0.8277	0.8008	HLA-DRB5	1
KEGG	hsa04014	Ras signaling pathway	2/80	232/8144	0.67	0.8277	0.8008	HGF/FASLG	2
KEGG	hsa04668	TNF signaling pathway	1/80	112/8144	0.6715	0.8277	0.8008	SOCS3	1
KEGG	hsa05145	Toxoplasmosis	1/80	112/8144	0.6715	0.8277	0.8008	HLA-DRB5	1
KEGG	hsa04724	Glutamatergic synapse	1/80	114/8144	0.678	0.8277	0.8008	GLUL	1
KEGG	hsa04151	PI3K-Akt signaling pathway	3/80	354/8144	0.6824	0.8277	0.8008	HGF/PRKAA1/FASLG	3
KEGG	hsa04020	Calcium signaling pathway	2/80	240/8144	0.6882	0.8277	0.8008	HGF/GNA15	2
KEGG	hsa04722	Neurotrophin signaling pathway	1/80	119/8144	0.6938	0.8277	0.8008	FASLG	1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	1/80	119/8144	0.6938	0.8277	0.8008	SOCS3	1
KEGG	hsa05132	Salmonella infection	2/80	249/8144	0.7077	0.8386	0.8113	RILP/GSDMD	2
KEGG	hsa00230	Purine metabolism	1/80	128/8144	0.7202	0.8394	0.8121	PAPSS1	1
KEGG	hsa04380	Osteoclast differentiation	1/80	128/8144	0.7202	0.8394	0.8121	SOCS3	1
KEGG	hsa04926	Relaxin signaling pathway	1/80	129/8144	0.723	0.8394	0.8121	GNA15	1
KEGG	hsa05322	Systemic lupus erythematosus	1/80	136/8144	0.7418	0.8459	0.8184	HLA-DRB5	1
KEGG	hsa04915	Estrogen signaling pathway	1/80	138/8144	0.7469	0.8459	0.8184	FKBP5	1
KEGG	hsa04371	Apelin signaling pathway	1/80	139/8144	0.7494	0.8459	0.8184	PRKAA1	1
KEGG	hsa05020	Prion disease	2/80	273/8144	0.7548	0.8459	0.8184	UQCRFS1/SDHA	2
KEGG	hsa05017	Spinocerebellar ataxia	1/80	143/8144	0.7593	0.8459	0.8184	ATXN3	1
KEGG	hsa03040	Spliceosome	1/80	147/8144	0.7688	0.8459	0.8184	SF3B1	1
KEGG	hsa04072	Phospholipase D signaling pathway	1/80	148/8144	0.7711	0.8459	0.8184	DGKE	1
KEGG	hsa04514	Cell adhesion molecules	1/80	149/8144	0.7734	0.8459	0.8184	HLA-DRB5	1
KEGG	hsa05226	Gastric cancer	1/80	149/8144	0.7734	0.8459	0.8184	HGF	1
KEGG	hsa01240	Biosynthesis of cofactors	1/80	153/8144	0.7823	0.8459	0.8184	ALPL	1
KEGG	hsa04921	Oxytocin signaling pathway	1/80	154/8144	0.7845	0.8459	0.8184	PRKAA1	1
KEGG	hsa04010	MAPK signaling pathway	2/80	294/8144	0.7905	0.8459	0.8184	HGF/FASLG	2
KEGG	hsa04060	Cytokine-cytokine receptor interaction	2/80	295/8144	0.7921	0.8459	0.8184	IL17RA/FASLG	2
KEGG	hsa04530	Tight junction	1/80	169/8144	0.8147	0.8647	0.8365	PRKAA1	1
KEGG	hsa05152	Tuberculosis	1/80	180/8144	0.8342	0.88	0.8513	HLA-DRB5	1
KEGG	hsa05034	Alcoholism	1/80	187/8144	0.8455	0.8865	0.8576	HDAC9	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/80	193/8144	0.8546	0.8906	0.8616	LYL1	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	1/80	197/8144	0.8604	0.8913	0.8623	FASLG	1
KEGG	hsa04510	Focal adhesion	1/80	201/8144	0.8659	0.8917	0.8626	HGF	1
KEGG	hsa04015	Rap1 signaling pathway	1/80	210/8144	0.8776	0.8983	0.8691	HGF	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/80	222/8144	0.8916	0.9053	0.8759	HLA-DRB5	1
KEGG	hsa05163	Human cytomegalovirus infection	1/80	225/8144	0.8949	0.9053	0.8759	FASLG	1
KEGG	hsa04740	Olfactory transduction	2/80	440/8144	0.9354	0.9409	0.9102	OR6N2/OR4C13	2
KEGG	hsa04080	Neuroactive ligand-receptor interaction	1/80	362/8144	0.9742	0.9742	0.9424	MTNR1B	1